Weak guidance typically leads to a loss of investor confidence and can result in a decrease in stock price as market participants adjust their expectations for future earnings and company growth. Given that the news directly pertains to Medifast's financial outlook, it is highly relevant and important for investors, leading to a high confidence in the negative short-term impact on the stock.